Immunoepidemilogy of p19:a potential vaccine candidate based on Plasmodium vivax MSP1

Simple item page
dc.contributor.authorWickramarachchi, W.T.A.
dc.contributor.authorPerera, K.L.R.L.
dc.contributor.authorBandara, S.
dc.contributor.authorLongacre, S.
dc.contributor.authorHandunetti, S.M.
dc.contributor.authorUdagama-Randeniya, P.V.
dc.date.accessioned2015-05-19T09:25:48Z
dc.date.available2015-05-19T09:25:48Z
dc.date.issued2000
dc.identifier.citationProceedings of the Twentieth Annual Sessions of the Institute of Biology, Sri Lanka, 2000
dc.identifier.reportnumberFR 1226
dc.identifier.researchgrantnumberSIDA/99/BT/001
dc.identifier.urihttps://dl.nsf.gov.lk/handle/1/19404
dc.subjectMedical Sciences
dc.subjectPlasmodium vivax
dc.subjectImmunoepidemiology
dc.subjectP19
dc.titleImmunoepidemilogy of p19:a potential vaccine candidate based on Plasmodium vivax MSP1
dc.typeProceedings

Files

Collections

Research Publications